409 related articles for article (PubMed ID: 34774086)
1. Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
Tsimafeyeu I; Volkova M; Alekseeva G; Berkut M; Nosov A; Myslevtsev I; Andrianov A; Semenov A; Borisov P; Zukov R; Goutnik V; Savchuk S; Dengina N; Mitin T
J Hematol Oncol; 2021 Nov; 14(1):192. PubMed ID: 34774086
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Logunov DY; Dolzhikova IV; Shcheblyakov DV; Tukhvatulin AI; Zubkova OV; Dzharullaeva AS; Kovyrshina AV; Lubenets NL; Grousova DM; Erokhova AS; Botikov AG; Izhaeva FM; Popova O; Ozharovskaya TA; Esmagambetov IB; Favorskaya IA; Zrelkin DI; Voronina DV; Shcherbinin DN; Semikhin AS; Simakova YV; Tokarskaya EA; Egorova DA; Shmarov MM; Nikitenko NA; Gushchin VA; Smolyarchuk EA; Zyryanov SK; Borisevich SV; Naroditsky BS; Gintsburg AL;
Lancet; 2021 Feb; 397(10275):671-681. PubMed ID: 33545094
[TBL] [Abstract][Full Text] [Related]
3. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
4. The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac.
Tonnara G; Piselli P; Cimaglia C; Arlotti M; Sacchini E; Manoni S; Zani A; Muccioli F; Laderchi A; Rabini S; Antinori A; Vaia F; Nicastri E; Girardi E
Clin Microbiol Infect; 2022 Dec; 28(12):1636-1643. PubMed ID: 35798146
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia.
Barchuk A; Bulina A; Cherkashin M; Berezina N; Rakova T; Kuplevatskaya D; Stanevich O; Skougarevskiy D; Okhotin A
BMC Public Health; 2022 Sep; 22(1):1803. PubMed ID: 36138385
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study.
Stoma I; Korsak K; Voropaev E; Osipkina O; Kovalev A
Heliyon; 2023 Nov; 9(11):e21877. PubMed ID: 38027828
[TBL] [Abstract][Full Text] [Related]
7. Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
Jarynowski A; Semenov A; Kamiński M; Belik V
J Med Internet Res; 2021 Nov; 23(11):e30529. PubMed ID: 34662291
[TBL] [Abstract][Full Text] [Related]
8. The Features of COVID-19's Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria.
Ptushkin V; Arshanskaya E; Vinogradova O; Kudlay D; Nikitin E
Hematol Rep; 2023 Sep; 15(3):503-512. PubMed ID: 37754667
[TBL] [Abstract][Full Text] [Related]
9. Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study.
Barchuk A; Bulina A; Cherkashin M; Berezina N; Rakova T; Kuplevatskaya D; Skougarevskiy D; Okhotin A
Respir Res; 2022 Oct; 23(1):276. PubMed ID: 36217139
[TBL] [Abstract][Full Text] [Related]
10. [Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial].
Avdeeva MG; Belousova ON; Orlova EA; Khamitov RF; Shvarts YG; Kravchenko IE
Ter Arkh; 2022 Dec; 94(11):1268-1277. PubMed ID: 37167165
[TBL] [Abstract][Full Text] [Related]
11. [The organizational aspects of security support of participants of clinical testing of vaccine "Gam-COVID-Vac"].
Naygovzina NB; Khabriev RU; Krasheninnikov AE; Matveev AV
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Jan; 29(1):5-13. PubMed ID: 33591649
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
13. Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study.
Barchuk A; Cherkashin M; Bulina A; Berezina N; Rakova T; Kuplevatskaya D; Stanevich O; Skougarevskiy D; Okhotin A
BMC Med; 2022 Sep; 20(1):312. PubMed ID: 36123681
[TBL] [Abstract][Full Text] [Related]
14. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance.
Di Valerio Z; La Fauci G; Soldà G; Montalti M; Lenzi J; Forcellini M; Barvas E; Guttmann S; Poluzzi E; Raschi E; Riccardi R; Fantini MP; Salussolia A; Gori D
EClinicalMedicine; 2022 Jul; 49():101468. PubMed ID: 35614901
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
González S; Olszevicki S; Salazar M; Calabria A; Regairaz L; Marín L; Campos P; Varela T; Martínez VVG; Ceriani L; Garcia E; Kreplak N; Pifano M; Estenssoro E; Marsico F
EClinicalMedicine; 2021 Oct; 40():101126. PubMed ID: 34541480
[TBL] [Abstract][Full Text] [Related]
16. Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge.
Dmitrieva K; Maslennikov R; Vasilieva E; Aliev S; Bakhitov V; Marcinkevich V; Levshina A; Kozlov E; Ivashkin V; Poluektova E
J Infect Public Health; 2023 Jun; 16(6):922-927. PubMed ID: 37086551
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study.
Mei Q; Hu G; Yang Y; Liu B; Yin J; Li M; Huang Q; Tang X; Böhner A; Bryant A; Kurts C; Yuan X; Li J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264438
[TBL] [Abstract][Full Text] [Related]
18. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance.
Montalti M; Soldà G; Di Valerio Z; Salussolia A; Lenzi J; Forcellini M; Barvas E; Guttmann S; Messina R; Poluzzi E; Raschi E; Riccardi R; Fantini MP; La Fauci G; Gori D;
EClinicalMedicine; 2021 Aug; 38():101027. PubMed ID: 34505029
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review.
Morón-Duarte LS; Chacón KR; Gutiérrez MP; De La Hoz IH; Yomayusa N
Biomedica; 2022 Oct; 42(Sp. 2):19-31. PubMed ID: 36322551
[TBL] [Abstract][Full Text] [Related]
20. Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
Meza L; Zengin Z; Salgia S; Malhotra J; Karczewska E; Dorff T; Tripathi A; Ely J; Kelley E; Mead H; Hsu J; Dizman N; Salgia N; Chawla N; Chehrazi-Raffle A; Muddasani R; Govindarajan A; Rock A; Liu S; Salgia R; Trent J; Altin J; Pal SK
Oncologist; 2023 Sep; 28(9):e748-e755. PubMed ID: 36971500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
